Teladoc Health Inc buy Royal Bank of Canada
Start price
26.04.24
/
50%
€12.29
Target price
26.04.25
€16.82
Performance (%)
-46.09%
Price
23.08.24
€6.63
Summary
This prediction is currently active. Massive losses of -46.09% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 26.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teladoc Health Inc | 2.665% | 2.665% |
iShares Core DAX® | 1.665% | 0.362% |
iShares Nasdaq 100 | -0.475% | -3.195% |
iShares Nikkei 225® | 2.620% | 1.174% |
iShares S&P 500 | -0.091% | -1.597% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€14.32
21.02.24
21.02.24
€23.12
21.02.25
21.02.25
-53.73%
23.08.24
23.08.24
Teladoc Health Inc
Start price
Target price
Perf. (%)
€16.46
25.10.23
25.10.23
€28.38
25.10.24
25.10.24
-59.74%
23.08.24
23.08.24